Pengfei Kong

1.5k total citations
41 papers, 1.1k citations indexed

About

Pengfei Kong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Pengfei Kong has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Pengfei Kong's work include Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Pengfei Kong is often cited by papers focused on Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Pengfei Kong collaborates with scholars based in China. Pengfei Kong's co-authors include Dazhi Xu, Youqing Zhan, Jianjun Liu, Xiaowei Sun, Xuechao Liu, Wenzhuo He, Chang Jiang, Lin Yang, Liangping Xia and Qiankun Xie and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Pengfei Kong

39 papers receiving 1.1k citations

Peers

Pengfei Kong

ONCOL

PRM

SURGE

Wenzhuo He China

Kazuhiko Yoshimatsu Japan

Andrea Spallanzani Italy

Lara Pijuán Spain

Kojiro Eto Japan

Seung‐Hoon Beom South Korea

David Liska United States

Türkkan Evrensel Türkiye

Keijiro Nozawa Japan

Lin Zhao China

Wenzhuo He China

Pengfei Kong

878 ×1.3

ONCOL

279 ×0.7

PRM

296 ×1.1

SURGE

325 ×1.4

241 ×1.4

Citations per year, relative to Pengfei Kong Pengfei Kong (= 1×) peers Wenzhuo He

Countries citing papers authored by Pengfei Kong

Since Specialization

Citations

This map shows the geographic impact of Pengfei Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Kong more than expected).

Fields of papers citing papers by Pengfei Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengfei Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Kong. The network helps show where Pengfei Kong may publish in the future.

Co-authorship network of co-authors of Pengfei Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Kong. A scholar is included among the top collaborators of Pengfei Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Kong. Pengfei Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Bo, Ping Xu, Pengfei Kong, Yantian Fang, & Hong Fu. (2023). Gastric adenocarcinoma in Situs inversus totalis: a case study and literature review. Frontiers in Oncology. 13. 1238467–1238467.

Chen, Shuo, et al.. (2023). Application of intravoxel incoherent motion diffusion-weighted magnetic resonance imaging on the diagnosis of breast cancer. 21(4). 827–832. 1 indexed citations

Liu, Fang, et al.. (2022). Zhizhu Decoction Alleviates Intestinal Barrier Damage via Regulating SIRT1/FoxO1 Signaling Pathway in Slow Transit Constipation Model Mice. Chinese Journal of Integrative Medicine. 29(9). 809–817. 17 indexed citations

Kong, Pengfei, et al.. (2022). Novel management indications for conservative treatment of chylous ascites after gastric cancer surgery. World Journal of Gastroenterology. 28(42). 6056–6067. 2 indexed citations

Ma, Mingzhe, Pengfei Kong, Yakai Huang, et al.. (2022). Activation of MAT2A-ACSL3 pathway protects cells from ferroptosis in gastric cancer. Free Radical Biology and Medicine. 181. 288–299. 50 indexed citations

Wu, Rui-Yan, Pengfei Kong, Liang-Ping Xia, et al.. (2019). Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma. Clinical Cancer Research. 25(14). 4530–4541. 80 indexed citations

Liu, Shousheng, Yuanzhong Yang, Chang Jiang, et al.. (2018). Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients. Journal of Translational Medicine. 16(1). 195–195. 16 indexed citations

Yang, Lin, Wenzhuo He, Qiankun Xie, et al.. (2018). Brain metastases in newly diagnosed colorectal cancer: a population-based study. Cancer Management and Research. Volume 10. 5649–5658. 13 indexed citations

Zhu, Junhao, Mengxue Yu, Pengfei Kong, et al.. (2018). Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model. Diagnostic and Interventional Imaging. 99(3). 135–142. 44 indexed citations

10.

Yang, Lin, Zhenchong Xiong, Wenzhuo He, et al.. (2018). Proximal shift of colorectal cancer with increasing age in different ethnicities. Cancer Management and Research. Volume 10. 2663–2673. 13 indexed citations

11.

He, Wenzhuo, Wanming Hu, Pengfei Kong, et al.. (2018). Systemic neutrophil lymphocyte ratio and mismatch repair status in colorectal cancer patients: correlation and prognostic value. Journal of Cancer. 9(17). 3093–3100. 22 indexed citations

12.

Xie, Qiankun, Wenzhuo He, Wanming Hu, et al.. (2018). Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality. Cancer Management and Research. Volume 10. 1365–1375. 18 indexed citations

13.

He, Wenzhuo, Qiankun Xie, Wanming Hu, et al.. (2018). An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients. Cancer Management and Research. Volume 10. 1597–1604. 15 indexed citations

14.

Xie, Qiankun, Ping Chen, Wanming Hu, et al.. (2018). The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor. Journal of Translational Medicine. 16(1). 273–273. 94 indexed citations

15.

He, Wenzhuo, Chang Jiang, Pengfei Kong, et al.. (2017). Primary Tumor Location as a Predictive Factor for First-line Bevacizumab Effectiveness in Metastatic Colorectal Cancer Patients. Journal of Cancer. 8(3). 388–394. 22 indexed citations

16.

Liu, Jianjun, Qirong Geng, Xuechao Liu, et al.. (2017). Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection. OncoTargets and Therapy. Volume 10. 2155–2162. 30 indexed citations

17.

Liu, Jianjun, Qirong Geng, Zhimin Liu, et al.. (2016). Development and external validation of a prognostic nomogram for gastric cancer using the national cancer registry. Oncotarget. 7(24). 35853–35864. 38 indexed citations

18.

Kong, Pengfei, Ruiyan Wu, Chenlu Yang, et al.. (2016). Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer. Scientific Reports. 6(1). 26313–26313. 14 indexed citations

19.

Kong, Pengfei, Ruiyan Wu, Xuechao Liu, et al.. (2016). The Effects of Anti-inflammatory Drug Treatment in Gastric Cancer Prevention: an Update of a Meta-analysis. Journal of Cancer. 7(15). 2247–2257. 28 indexed citations

20.

Liu, Xuechao, Xiaowei Sun, Jianjun Liu, et al.. (2015). Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer. Translational Oncology. 8(4). 339–345. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact